Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis

NCT06053255 is registered in ClinicalTrials.gov with FUSMobile Inc. as lead sponsor.

NCT NCT06053255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06053255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis
Lead sponsor
FUSMobile Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 13, 2024
Completion date
December 15, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sacroiliitis